Mental Health DailyResearch. Evidence. Perspective.Published research on guanfacine.
Three men with ADHD and lifelong tics, treated at a Tokyo clinic, saw their tics ease soon after starting a low dose of guanfacine, a non-stimulant ADHD medication, according to a 2026 case …
Read articleGuanfacine, a non-stimulant ADHD medication, reduced hyperactivity in autistic children in a placebo-controlled trial. A 2026 review argues it may also steady prefrontal brain signaling and …
Read articleA 2026 case report linked 1 mg nightly guanfacine modified-release to first-ever cessation of intrusive deliberate self-harm thoughts in a 16-year-old with attention-deficit/hyperactivity di…
Read articleReports suggest that nearly 20% of all people in the United States are taking a psychiatric drug. This means that 1 out of every 5 people you see is on some sort of mind-altering medication.…
Read articleGuanfacine is a drug that was developed primarily for the treatment of hypertension (high blood pressure). It has been proven as an effective medication to reduce both systolic and diastolic…
Read article
